Hopital de Hautepierre CHRU de Strasbourg

Strasbourg 67091

0 studies enrolling now · 2 studies all time

What they study most

Myelodysplastic Syndrome, NMO Spectrum Disorder (NMOSD), Neuromyelitis Optica (NMO)

Studies at this site

• Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD) — Completed
• Non-interventional Study of Lenalidomide in the Clinical Routine Treatment of TD Patients With IPSS Low or Int-1 MDS and Isolated Del(5q) — Completed